What is he best known for?
The fields of study he is best known for:
- Cognition
- World War II
- Internal medicine
His primary areas of study are Parkinson's disease, Disease, Psychiatry, Cognition and Dementia.
The study incorporates disciplines such as Frontal lobe, Neuroscience, Quality of life, Mood and Physical therapy in addition to Parkinson's disease.
His research links Depression with Disease.
His Psychiatry study deals with Central nervous system disease intersecting with Transplantation, Progressive supranuclear palsy and Pediatrics.
His Cognition study integrates concerns from other disciplines, such as Stimulus, Cognitive psychology, Audiology and Parkinsonism.
The various areas that Richard Brown examines in his Dementia study include Alzheimer's disease and Psychometrics.
His most cited work include:
- Clinical diagnostic criteria for dementia associated with Parkinson's disease. (1812 citations)
- Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects (864 citations)
- Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force (726 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Parkinson's disease, Psychiatry, Disease, Cognition and Clinical psychology.
Richard Brown has included themes like Central nervous system disease, Neuroscience, Physical therapy and Physical medicine and rehabilitation in his Parkinson's disease study.
His studies in Psychiatry integrate themes in fields like Randomized controlled trial and Dementia.
When carried out as part of a general Disease research project, his work on Degenerative disease and Apathy is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
His study in Cognition is interdisciplinary in nature, drawing from both Developmental psychology and Audiology.
His Clinical psychology research includes elements of Psychosocial and Personality.
He most often published in these fields:
- Parkinson's disease (33.66%)
- Psychiatry (27.06%)
- Disease (27.39%)
What were the highlights of his more recent work (between 2012-2021)?
- Parkinson's disease (33.66%)
- Disease (27.39%)
- Psychiatry (27.06%)
In recent papers he was focusing on the following fields of study:
Parkinson's disease, Disease, Psychiatry, Anxiety and Cognition are his primary areas of study.
His Parkinson's disease study is concerned with the larger field of Internal medicine.
His Disease research includes themes of Physical therapy, Distress and Quality of life.
His Psychiatry research is multidisciplinary, incorporating perspectives in Donepezil, Clinical trial, Randomized controlled trial and Clinical psychology.
His study looks at the relationship between Clinical psychology and fields such as Depression, as well as how they intersect with chemical problems.
His Cognition study which covers Dementia that intersects with Neuropsychology and Developmental psychology.
Between 2012 and 2021, his most popular works were:
- Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery (127 citations)
- Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group (121 citations)
- Is language impairment more common than executive dysfunction in amyotrophic lateral sclerosis (119 citations)
In his most recent research, the most cited papers focused on:
- Cognition
- World War II
- Internal medicine
His primary areas of investigation include Parkinson's disease, Disease, Physical therapy, Anxiety and Progressive supranuclear palsy.
Parkinson's disease is closely attributed to Clinical trial in his work.
His research integrates issues of Cognitive behavioral therapy, Quality of life and Clinical psychology in his study of Disease.
His Quality of life research focuses on Optimism and how it relates to Mood and Psychiatry.
His biological study spans a wide range of topics, including Randomized controlled trial, Distress, Levodopa, Cohort and Apomorphine.
His Progressive supranuclear palsy study combines topics from a wide range of disciplines, such as Frontal lobe and Neuroscience.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
